Heart failure cohort links recorded cannabis disorder to more hospitalizations

Cannabis-related disorders, hospitalization, and cardiovascular outcomes in patients with heart failure: A real-world propensity-matched cohort study.

Clinical research in cardiology : official journal of the German Cardiac Society • • Highly Relevant
🤖

AI Summary

This retrospective, propensity-matched cohort study asked whether a documented cannabis-related disorder was associated with hospitalization and cardiovascular outcomes among adults with heart failure. Using US health-record data, researchers matched 30,624 patients in each cohort and compared those with a recorded disorder against those without one. At one year, the disorder was associated with more all-cause hospitalization: 57.5% versus 45.1% (HR 1.468). This was an observational association, not evidence that cannabis exposure caused the difference.

The disorder was also associated with higher all-cause mortality, stroke, and myocardial infarction. Atrial fibrillation/flutter and end-stage renal disease did not differ between cohorts. The study’s key limitation is that a recorded disorder is not a precise measure of cannabis exposure, and the retrospective design cannot establish causation; the authors call for prospective studies that characterize exposure more precisely. This is an abstract-based summary, not a review of the full paper.

💡 Key Findings

1
Among matched heart-failure patients, a recorded cannabis-related disorder was associated with higher one-year all-cause hospitalization: 57.5% versus 45.1%.
High
80%
2
Recorded disorder was associated with higher all-cause mortality (10.4% vs 9.3%), stroke (2.9% vs 2.3%), and myocardial infarction (6.0% vs 4.4%).
High
80%
3
Atrial fibrillation/flutter and end-stage renal disease did not differ between the matched cohorts.
High
80%
4
Because this was a retrospective observational study and the exposure was a documented disorder rather than precisely characterized cannabis use, it cannot establish that cannabis caused these outcomes.
High
95%

📄 Original Abstract

BACKGROUND: The clinical implications of cannabis exposure in patients with heart failure remain uncertain. We evaluated the associations between a documented cannabis-related disorder (CRD) and hospitalization and cardiovascular outcomes in a large real-world heart failure cohort. METHODS: We performed a retrospective cohort study using the TriNetX US Collaborative Network. Adult patients with heart failure (ICD-10-CM I50) were identified and stratified by the presence or absence of cannabis-related disorder (ICD-10-CM F12) recorded within 1 year on or before the first heart failure diagnosis, which served as the index date. The primary outcome was all-cause hospitalization at 1 year. Secondary outcomes included stroke, myocardial infarction, end-stage renal disease, atrial fibrillation/flutter, and all-cause mortality. Follow-up began 1 day after the index date; patients with a prior history of a given outcome were excluded from that analysis. One-to-one propensity score matching was performed using 26 baseline covariates. RESULTS: After matching, 30,624 patients were included in each cohort. At 1 year, a documented CRD was associated with a higher risk of hospitalization (57.5% vs. 45.1%; HR, 1.468; 95% CI, 1.436-1.501; p < 0.001). A documented CRD was also associated with significantly higher all-cause mortality (10.4% vs 9.3%; HR, 1.147; 95% CI, 1.090-1.207; p < 0.001), stroke (2.9% vs 2.3%; HR, 1.263; 95% CI, 1.138-1.401; p < 0.001), and myocardial infarction (6.0% vs 4.4%; HR, 1.415; 95% CI, 1.307-1.531; p < 0.001). Atrial fibrillation/flutter and end-stage renal disease did not differ. The hospitalization association persisted after excluding the first 30 days of follow-up (HR 1.252; 95% CI 1.226-1.280; p < 0.001), was similar in women and men, and remained in multivariable Cox models (adjusted HR 1.521; 95% CI 1.503-1.539; p < 0.001). CONCLUSIONS: In this real-world propensity score-matched cohort of patients with heart failure, a documented cannabis-related disorder was associated with higher risks of hospitalization and selected adverse cardiovascular outcomes. Prospective studies with precise cannabis exposure characterization are needed to confirm these associations.

Explore More Research

Stay informed about the latest cannabis science.

Your stash, decoded.